Search

everythinglearnresearchcommunity

for

Search:↓

Changing neuroactive steroids in baby male rats affects their memory and learning differently as they grow up.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

The document concludes that more research is needed to confirm if COVID-19 vaccines cause a type of hair loss called alopecia areata.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

Sarcoidosis can cause severe high calcium levels, hair loss, and kidney failure.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

The new method can create hair follicle-like structures but not complete hair with roots and shafts, needing more improvement.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Convalescent Plasma Therapy may help treat COVID-19 Long-Hauler symptoms.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

PRP shows promise for hair loss treatment, but needs standardized preparation and composition.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

The new delivery method for dutasteride is more effective and has fewer side effects.

The method safely and efficiently delivers genes to the skin but may not work for conditions needing high levels of gene products.